Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (201-210 of 534) with videos related to

Pageof 54
Sort By:
Cell Reports|May 26, 2021
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cellsEvan D Rossignol, Anne-Sophie Dugast, Hacheming Compere, et al.
Nature Communications|August 24, 2023
Antibody-mediated NK cell activation as a correlate of immunity against influenza infectionCarolyn M Boudreau, John S Burke, Ashraf S Yousif, et al.
Mbio|April 13, 2026
Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammationSamantha R Mackin, Chieh-Yu Liang, Courtney E Karl, et al.
Iscience|April 20, 2026
Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothersNadege Nziza, Wonyeong Jung, Yunjoo Lee, et al.
Frontiers in Immunology|November 16, 2020
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γAndy C Tran, Gil R Diogo, Matthew J Paul, et al.
Vaccines|October 27, 2022
Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated MothersMadeleine D Burns, Cordelia Muir, Caroline Atyeo, et al.
Nature Reviews. Immunology|June 14, 2018
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D Simmons, Catherine M Stein, Chetan Seshadri, et al.
Nature Microbiology|April 3, 2023
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Plos Pathogens|August 24, 2018
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan capPhilipp A Ilinykh, Rodrigo I Santos, Bronwyn M Gunn, et al.
Frontiers in Immunology|July 22, 2021
Antibody Subclass and Glycosylation Shift Following Effective TB TreatmentPatricia S Grace, Sepideh Dolatshahi, Lenette L Lu, et al.
Pageof 54

Showing results (201-210 of 534) with videos related to

Sort By:
Pageof 54
Cell Reports|May 26, 2021
Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cellsEvan D Rossignol, Anne-Sophie Dugast, Hacheming Compere, et al.
Nature Communications|August 24, 2023
Antibody-mediated NK cell activation as a correlate of immunity against influenza infectionCarolyn M Boudreau, John S Burke, Ashraf S Yousif, et al.
Mbio|April 13, 2026
Fc-engineered antibodies enhance protection against SARS-CoV-2 lung infection and inflammationSamantha R Mackin, Chieh-Yu Liang, Courtney E Karl, et al.
Iscience|April 20, 2026
Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothersNadege Nziza, Wonyeong Jung, Yunjoo Lee, et al.
Frontiers in Immunology|November 16, 2020
Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γAndy C Tran, Gil R Diogo, Matthew J Paul, et al.
Vaccines|October 27, 2022
Relationship between Anti-Spike Antibodies and Risk of SARS-CoV-2 Infection in Infants Born to COVID-19 Vaccinated MothersMadeleine D Burns, Cordelia Muir, Caroline Atyeo, et al.
Nature Reviews. Immunology|June 14, 2018
Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infectionJason D Simmons, Catherine M Stein, Chetan Seshadri, et al.
Nature Microbiology|April 3, 2023
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2Samantha R Mackin, Pritesh Desai, Bradley M Whitener, et al.
Plos Pathogens|August 24, 2018
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan capPhilipp A Ilinykh, Rodrigo I Santos, Bronwyn M Gunn, et al.
Frontiers in Immunology|July 22, 2021
Antibody Subclass and Glycosylation Shift Following Effective TB TreatmentPatricia S Grace, Sepideh Dolatshahi, Lenette L Lu, et al.
Pageof 54